|
May 12
|
Alterity Therapeutics Prominently Featured at the International MSA Congress
|
|
May 7
|
Alterity Therapeutics Announces Multiple Oral and Poster Presentations to be Featured at the International MSA Congress
|
|
May 5
|
Alterity Therapeutics Granted U.S. FDA Fast Track Designation for ATH434 to Treat Multiple System Atrophy
|
|
Apr 30
|
Appendix 4C – Q3 FY25 Quarterly Cash Flow Report
|
|
Apr 28
|
Alterity Therapeutics Presents ATH434-201 Phase 2 Clinical Trial Results at European MSA Symposium
|
|
Mar 12
|
3 Promising ASX Penny Stocks With Market Caps Over A$20M
|
|
Mar 10
|
Alterity Therapeutics (ATHE): Among the Best Australian Stocks to Buy According to Billionaires
|